DE60043146D1 - Immuntest für humanes Medullasin und Verfahren zur Diagnose von multipler Sklerose - Google Patents

Immuntest für humanes Medullasin und Verfahren zur Diagnose von multipler Sklerose

Info

Publication number
DE60043146D1
DE60043146D1 DE60043146T DE60043146T DE60043146D1 DE 60043146 D1 DE60043146 D1 DE 60043146D1 DE 60043146 T DE60043146 T DE 60043146T DE 60043146 T DE60043146 T DE 60043146T DE 60043146 D1 DE60043146 D1 DE 60043146D1
Authority
DE
Germany
Prior art keywords
medullasin
immunoassay
blood
human medullasin
multiple sclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60043146T
Other languages
English (en)
Inventor
Hideaki Suzuki
Kiyoshi Takahashi
Hisashi Katsuragi
Yosuke Aoki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainichiseika Color and Chemicals Mfg Co Ltd
Original Assignee
Dainichiseika Color and Chemicals Mfg Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000026828A external-priority patent/JP4037586B2/ja
Priority claimed from JP2000121587A external-priority patent/JP4422291B2/ja
Application filed by Dainichiseika Color and Chemicals Mfg Co Ltd filed Critical Dainichiseika Color and Chemicals Mfg Co Ltd
Application granted granted Critical
Publication of DE60043146D1 publication Critical patent/DE60043146D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/285Demyelinating diseases; Multipel sclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60043146T 2000-02-03 2000-10-25 Immuntest für humanes Medullasin und Verfahren zur Diagnose von multipler Sklerose Expired - Lifetime DE60043146D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000026829 2000-02-03
JP2000026828A JP4037586B2 (ja) 2000-02-03 2000-02-03 ヒトメダラシンの免疫学的測定方法
JP2000121587A JP4422291B2 (ja) 2000-04-21 2000-04-21 ヒトメダラシンの免疫学的測定方法

Publications (1)

Publication Number Publication Date
DE60043146D1 true DE60043146D1 (de) 2009-11-26

Family

ID=27342238

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60043146T Expired - Lifetime DE60043146D1 (de) 2000-02-03 2000-10-25 Immuntest für humanes Medullasin und Verfahren zur Diagnose von multipler Sklerose

Country Status (11)

Country Link
US (2) US6767709B1 (de)
EP (1) EP1122543B1 (de)
CN (1) CN1237346C (de)
AT (1) ATE445840T1 (de)
AU (1) AU784387B2 (de)
CA (1) CA2327414C (de)
DE (1) DE60043146D1 (de)
ES (1) ES2334972T3 (de)
NO (1) NO328316B1 (de)
PL (1) PL205979B1 (de)
RU (1) RU2210074C2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004034031A2 (en) * 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
DE102009010563A1 (de) 2009-02-16 2010-08-26 Matthias W. Engel Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
CN108051590B (zh) 2013-09-13 2020-12-11 Symbolics有限责任公司 运用二维试验和对照信号读出模式的侧向层析检测

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745071A (en) * 1985-09-05 1988-05-17 Sequoia-Turner Corporation Method for the volumetric differentiation of blood cells types
JPH01151085A (ja) 1987-12-08 1989-06-13 Nec Corp 磁気ヘッド位置決め機講
JP3209409B2 (ja) 1997-07-31 2001-09-17 小倉クラッチ株式会社 電磁スプリングクラッチ
JP4071330B2 (ja) * 1997-11-20 2008-04-02 大日精化工業株式会社 抗ヒトメダラシンモノクローナル抗体、その製造方法及びそれを用いる免疫学的測定方法

Also Published As

Publication number Publication date
CN1237346C (zh) 2006-01-18
PL205979B1 (pl) 2010-06-30
CA2327414C (en) 2010-09-28
AU7218000A (en) 2001-08-09
US20050019957A1 (en) 2005-01-27
EP1122543B1 (de) 2009-10-14
PL345608A1 (en) 2001-08-13
NO20010175D0 (no) 2001-01-11
ES2334972T3 (es) 2010-03-18
ATE445840T1 (de) 2009-10-15
EP1122543A1 (de) 2001-08-08
US7081348B2 (en) 2006-07-25
NO20010175L (no) 2001-08-06
CN1307237A (zh) 2001-08-08
US6767709B1 (en) 2004-07-27
AU784387B2 (en) 2006-03-23
NO328316B1 (no) 2010-01-25
RU2210074C2 (ru) 2003-08-10
CA2327414A1 (en) 2001-08-03

Similar Documents

Publication Publication Date Title
ATE410687T1 (de) Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test
JP2019535015A5 (de)
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
ATE100591T1 (de) Vorrichtung und verfahren zur bestimmung eines analyten.
WO2005112742A3 (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
RU95106504A (ru) Набор для проведения анализа, электронное устройство, аналитическое устройство, способ контроля за состоянием цикла, способ определения фертильного периода (варианты), устройство контроля за циклом, набор для контроля цикла и набор одноразовых приспособлений (варианты)
RU2008103988A (ru) Способ диагностики рассеяного склероза
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
JP2008504551A5 (de)
DE69941627D1 (de) Für krebs
DE60043146D1 (de) Immuntest für humanes Medullasin und Verfahren zur Diagnose von multipler Sklerose
EP3221444B1 (de) Lateralflussassayverhältnistest
CA2274776A1 (en) Method for analyzing annexin v in urine and use thereof
DE60232595D1 (de) Methode zur diagnose von nierenerkrankungen
DE50103032D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 19-9
JP4272065B2 (ja) Ca125の測定による敗血症の検出方法
DE60112949D1 (de) Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes
CN114618853A (zh) 一种样本分析仪的清洗方法及样本分析仪
RU2299006C2 (ru) Способ диагностики артериальной гипертензии, вызванной беременностью
JP4735503B2 (ja) 腹膜機能マーカー、その分析方法およびその用途
DE602004019134D1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
KR950009257A (ko) 골다공증 진단제
ATE466285T1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
RU94007469A (ru) Способ диагностики сосудистых нарушений у беременных на раннем этапе развития патологического течения гестации
RU2741699C1 (ru) Способ диагностики дисплазии соединительной ткани у новорожденного

Legal Events

Date Code Title Description
8364 No opposition during term of opposition